Landmark TrialRCTRandomized Controlled Trial
Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke
New England Journal of Medicine2014IF: 25.4
Eric Jüttler, Andreas Unterberg, Johannes Woitzik, Julian Bösel, Hemasse Amiri, Oliver Sakowitz, Matthias Gondan, Petra Schiller, Ronald Limprecht, Steffen Luntz, Hauke Schneider, Thomas Pinzer, Carsten Hobohm, Jürgen Meixensberger, Werner Hacke
Abstract
Hemicraniectomy increased survival without severe disability among patients 61 years of age or older with a malignant middle-cerebral-artery infarction. The majority of survivors required assistance with most bodily needs. (Funded by the Deutsche Forschungsgemeinschaft; DESTINY II Current Controlled Trials number, ISRCTN21702227.).